These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

415 related articles for article (PubMed ID: 18021362)

  • 1. Adjuvant effects of bacillus Calmette-Guerin DNA or CpG-oligonucleotide in the immune response to Taenia solium cysticercosis vaccine in porcine.
    Guo YJ; Wu D; Wang KY; Sun SH
    Scand J Immunol; 2007 Dec; 66(6):619-27. PubMed ID: 18021362
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of pigs against Taenia solium cysticercosis using recombinant antigen or in combination with DNA vaccine.
    Guo YJ; Sun SH; Zhang Y; Chen ZH; Wang KY; Huang L; Zhang S; Zhang HY; Wang QM; Wu D; Zhu WJ
    Vaccine; 2004 Sep; 22(29-30):3841-7. PubMed ID: 15364430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of protection against porcine cysticercosis in growing pigs by DNA vaccination.
    Guo A; Jin Z; Zheng Y; Hai G; Yuan G; Li H; Cai X
    Vaccine; 2007 Jan; 25(1):170-5. PubMed ID: 16750874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of protection against porcine cysticercosis by vaccination with recombinant oncosphere antigens.
    Flisser A; Gauci CG; Zoli A; Martinez-Ocaña J; Garza-Rodriguez A; Dominguez-Alpizar JL; Maravilla P; Rodriguez-Canul R; Avila G; Aguilar-Vega L; Kyngdon C; Geerts S; Lightowlers MW
    Infect Immun; 2004 Sep; 72(9):5292-7. PubMed ID: 15322025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody responses and epitope specificities to the Taenia solium cysticercosis vaccines TSOL18 and TSOL45-1A.
    Kyngdon CT; Gauci CG; Gonzalez AE; Flisser A; Zoli A; Read AJ; Martínez-Ocaña J; Strugnell RA; Lightowlers MW
    Parasite Immunol; 2006 May; 28(5):191-9. PubMed ID: 16629704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG motif in ATCGAT hexamer improves DNA-vaccine efficiency against lethal Pseudorabies virus infection in pigs.
    Dory D; Béven V; Torché AM; Bougeard S; Cariolet R; Jestin A
    Vaccine; 2005 Aug; 23(36):4532-40. PubMed ID: 15921828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic capacity of the synthetic peptide-based vaccine against Taenia solium cysticercosis in pigs.
    de Aluja AS; Villalobos NM; Nava G; Toledo A; Martínez JJ; Plancarte A; Rodarte LF; Fragoso G; Sciutto E
    Vaccine; 2005 Jul; 23(31):4062-9. PubMed ID: 15927324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to swine streptococcic septicemia vaccine in weaned piglets.
    Linghua Z; Xingshan T; Fengzhen Z
    Mol Immunol; 2007 Feb; 44(6):1141-9. PubMed ID: 16911828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Toward development of a Taenia solium paramyosin-based vaccine against porcine cysticercosis].
    Solís CF; Vázquez-Talavera J; Laclette JP
    Gac Med Mex; 2004; 140(2):129-38. PubMed ID: 15162945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CpG-ODN combined with Neospora caninum lysate, but not with excreted-secreted antigen, enhances protection against infection in mice.
    Ribeiro DP; Freitas MM; Cardoso MR; Pajuaba AC; Silva NM; Mineo TW; Silva JS; Mineo JR; Silva DA
    Vaccine; 2009 Apr; 27(19):2570-9. PubMed ID: 19428863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CpG-oligodeoxynucleotides enhance porcine immunity to Toxoplasma gondii.
    Kringel H; Dubey JP; Beshah E; Hecker R; Urban JF
    Vet Parasitol; 2004 Aug; 123(1-2):55-66. PubMed ID: 15265571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the development of DNA vaccine against Cysticercus cellulosae infection and its efficacy.
    Cai X; Chai Z; Jing Z; Wang P; Luo X; Chen J; Dou Y; Feng S; Su C; Jin J
    Southeast Asian J Trop Med Public Health; 2001; 32 Suppl 2():105-10. PubMed ID: 12041570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis.
    Wedlock DN; Skinner MA; de Lisle GW; Vordermeier HM; Hewinson RG; Hecker R; van Drunen Littel-van den Hurk S; Babiuk LA; Buddle BM
    Vet Immunol Immunopathol; 2005 Jun; 106(1-2):53-63. PubMed ID: 15910992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with Leishmania soluble antigen and immunostimulatory oligodeoxynucleotides induces specific immunity and protection against Leishmania donovani infection.
    Tewary P; Pandya J; Mehta J; Sukumaran B; Madhubala R
    FEMS Immunol Med Microbiol; 2004 Oct; 42(2):241-8. PubMed ID: 15364110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CpG oligodeoxynucleotide augments HSV-2 glycoprotein D DNA vaccine efficacy to generate T helper 1 response and subsequent protection against primary genital herpes infection in mice.
    Tengvall S; Josefsson A; Holmgren J; Harandi AM
    J Reprod Immunol; 2005 Dec; 68(1-2):53-69. PubMed ID: 16229896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the S3Pvac vaccine against porcine Taenia solium cysticercosis: a historical review.
    Sciutto E; Fragoso G; Hernández M; Rosas G; Martínez JJ; Fleury A; Cervantes J; Aluja A; Larralde C
    J Parasitol; 2013 Aug; 99(4):686-92. PubMed ID: 23445359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunostimulatory capacity of DNA vaccine vectors in porcine PBMC: a specific role for CpG-motifs?
    Verfaillie T; Cox E; Goddeeris BM
    Vet Immunol Immunopathol; 2005 Jan; 103(1-2):141-51. PubMed ID: 15626469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inexpensive anti-cysticercosis vaccine: S3Pvac expressed in heat inactivated M13 filamentous phage proves effective against naturally acquired Taenia solium porcine cysticercosis.
    Morales J; Martínez JJ; Manoutcharian K; Hernández M; Fleury A; Gevorkian G; Acero G; Blancas A; Toledo A; Cervantes J; Maza V; Quet F; Bonnabau H; de Aluja AS; Fragoso G; Larralde C; Sciutto E
    Vaccine; 2008 Jun; 26(23):2899-905. PubMed ID: 18440675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunostimulatory oligodeoxynucleotides are potent enhancers of protective immunity in mice immunized with recombinant ORFF leishmanial antigen.
    Tewary P; Sukumaran B; Saxena S; Madhubala R
    Vaccine; 2004 Aug; 22(23-24):3053-60. PubMed ID: 15297055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CpG immuno-stimulatory motifs enhance humoral immune responses against hepatitis C virus core protein after DNA-based immunization.
    Encke J; zu Putlitz J; Stremmel W; Wands JR
    Arch Virol; 2003 Mar; 148(3):435-48. PubMed ID: 12607097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.